Knygos.lt klubas Knygos.lt nariams
342,03 €
-15%
Įprastai
402,39 €
Histone Modifiers and Targeted Drugs in Cancer Immunotherapy
Histone Modifiers and Targeted Drugs in Cancer Immunotherapy
Knygos.lt klubas Knygos.lt nariams
342,03 €
-15%
Įprastai
402,39 €
  • Planuojame turėti už 63 d.
This book aims to provides an overview of the advancements in histone modifiers and their targeted drugs in the field of cancer immunotherapy. It systematically examines the biological relationships between diverse histone modifications and tumor immunity, as well as the development of targeted inhibitors and degraders, drawing from clinical and literature research. This book will help readers understand the latest research advancements and guide them in the practice of cancer immunotherapy. Th…

Histone Modifiers and Targeted Drugs in Cancer Immunotherapy (el. knyga) (skaityta knyga) | knygos.lt

Atsiliepimai

Aprašymas

This book aims to provides an overview of the advancements in histone modifiers and their targeted drugs in the field of cancer immunotherapy. It systematically examines the biological relationships between diverse histone modifications and tumor immunity, as well as the development of targeted inhibitors and degraders, drawing from clinical and literature research. This book will help readers understand the latest research advancements and guide them in the practice of cancer immunotherapy. The book is likely to be of interest to researchers in the field of new drug development and relevant graduate students.

Knygos.lt klubas
Knygos.lt nariams
342,03 €
-15%
Įprastai
402,39 €
Kaina registruotiems pirkėjams
Prisijunkite ir už šią prekę
gausite 3,42 Knygų Eurų!?
Planuojame turėti už 63 d.
Įsigykite dovanų kuponą
Daugiau

This book aims to provides an overview of the advancements in histone modifiers and their targeted drugs in the field of cancer immunotherapy. It systematically examines the biological relationships between diverse histone modifications and tumor immunity, as well as the development of targeted inhibitors and degraders, drawing from clinical and literature research. This book will help readers understand the latest research advancements and guide them in the practice of cancer immunotherapy. The book is likely to be of interest to researchers in the field of new drug development and relevant graduate students.

Atsiliepimai

  • Atsiliepimų nėra
0 pirkėjai įvertino šią prekę.
5
0%
4
0%
3
0%
2
0%
1
0%
(rodomas nebus)